Serious Risks (Seek Medical Care) Contact a healthcare provider immediately if you experience: Severe abdominal pain (possible pancreatitis), Vision changes, Persistent vomiting or dehydration, Signs of allergic reaction (swelling, breathing difficulty) Low Blood Sugar Risk increases when used with insulin or certain diabetes medications
European journal of pharmacology, 495(2-3), 201-208
While the GLP-1RA drugs have traditionally been used in type 2 diabetics, their ability to cause weight loss has captured the minds and imaginations of patients, providers, and drug manufacturers alike
This hormone signals the pancreas to release insulin, which helps lower blood sugar by allowing cells to absorb glucose
Second Natures Wegovy programme combines the medication with support from registered dietitians and a structured habit-change programme, built around the balanced plate model and sustainable changes rather than restrictive dieting
Typically, Semaglutide GLP-1 injections are recommended for individuals with a BMI of 30 or higher, or 27 or higher with weight-related health conditions